Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Coldiron, Matthew E ^a   Lasry, Estrella ^b   Bouhenia, Malika ^a   Das, Debashish ^a   Okui, Peter ^c   Nyehangane, Dan ^a   Mwanga, Juliet ^a   Langendorf, Celine ^a   Elder, Greg ^a   Salumu, Léon ^a   Grais, Rebecca F ^a  

^a EPICENTRE   (France)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c MINISTRY OF HEALTH   (Uganda)

Author keywords

Anti malarials; Artemisinin; Malaria; Quinolines; Refugee; South Sudan; Uganda

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ARTICLE; DISEASE SEVERITY; DOCUMENTATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH PROGRAM; HUMAN; INCIDENCE; INTERVENTION STUDY; MALARIA; MEDICATION COMPLIANCE; MICROSCOPY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; REFUGEE CAMP; UGANDA; ADOLESCENT; CHILD; CROSS-SECTIONAL STUDY; DRUG COMBINATION; FEMALE; INFANT; MALE; PARASITEMIA; PARASITOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; FEMALE; HUMANS; INCIDENCE; INFANT; MALARIA; MALE; PARASITEMIA; PREVALENCE; QUINOLINES; REFUGEE CAMPS; UGANDA;

EID: 85019913833     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1869-x     Document Type: Article

References (15)

1. WHO Global Malaria Programme. WHO policy recommendation: seasonal Malaria Chemoprevention for Plasmodium falciparum control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: WHO; 2012.
2. WHO. Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva: World Health Organization; 2010.
3. World Health Organization. Updated policy recommendation: intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva: World Health Organization; 2012.
4. Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, et al. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis. 2014;58:1404-12.
5. Anderson J, Doocy S, Haskew C, Spiegel P, Moss WJ. The burden of malaria in post-emergency refugee sites: a retrospective study. Confl Health. 2011;5:17.
6. Charchuk R, Makelele KJP, Kasereka MC, Houston S, Hawkes MT. Burden of malaria is higher among children in an internal displacement camp compared to a neighbouring village in the Democratic Republic of the Congo. Malar J. 2016;15:431.
7. Lwin KM, Phyo AP, Tarning J, Hanpithakpong W, Ashley EA, Lee SJ, et al. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob Agents Chemother. 2012;56:1571-7.
8. United Nations High Commissioner for Refugees. South Sudan situation-regional overview.
9. Uganda Bureau of Statistics. ICF International. Uganda malaria indicator survey 2014-2015. Kampala: Uganda Bureau of Statistics; 2015.
10. WHO. Basic malaria microscopy-2nd edition learner’s guide. Geneva: World Health Organization; 2010.
11. Allen EN, Chandler CI, Mandimika N, Pace C, Mehta U, Barnes KI. Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data. Malar J. 2013;12:325.
12. CIOMS. Management of safety information from clinical trials. Geneva: Council for International Organizations of Medical Sciences; 2005.
13. Mehta U, Allen E, Barnes KI. Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria. Expert Rev Clin Pharmacol. 2010;3:509-25.
14. Pasquale H, Jarvese M, Julla A, Doggale C, Sebit B, Lual MY, et al. Malaria control in South Sudan, 2006-2013: strategies, progress and challenges. Malar J. 2013;12:374.
15. WorldWide Antimalarial Resistance Network (WWARN) DP Study Group. The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data. PLoS Med. 2013;10:1-17.